Answers are grounded in this paper and cite their sources.
Background This study aimed to evaluate the effect of concentrated growth factors (CGF) on bone formation following osteotome sinus floor elevation (OSFE) using cone beam computed tomography (CBCT) and Mimics software. Methods A total of 36 patients (10 males and 26 females) were enrolled and divided into three groups according to the sinus grafting strategy: Group A (OSFE with CGF alone), Group B (OSFE with CGF combined with xenogeneic bone graft), and Group C (OSFE alone without grafting). Baseline characteristics, postoperative discomfort (visual analogue scale, VAS), and radiographic data were collected for all patients. Results Patients in Groups A and C were reported less postoperative pain than those in Group B ( P < 0.05). At both immediate and 6-month post‑surgery assessments, endo‑sinus bone augmentation volume was significantly higher in Groups A (228.0 and 161.2 mm³) and B (213.9 and 152.1 mm³) than in Group C (141.2 and 95.8 mm³) ( P < 0.05). The maxillary sinus bone density change rate was also significantly higher in Groups A (150.6%) and B (129.3%) than in Group C (62.7%) ( P < 0.05). However, no significant difference was found in the mean rate of maxillary sinus bone volume change among the three groups ( P > 0.05). Conclusion In OSFE with an elevation height ≤ 4 mm, CGF alone or in combination with bone graft materials achieved favorable bone augmentation and promoted new bone formation, with outcomes significantly superior to those of OSFE without any graft material. However, the addition of bone graft materials may aggravate postoperative discomfort. Trial registration The study protocol was retrospectively registered in the Chinese Clinical Trial Registry. ChiCTR ID is ChiCTR2600124306. Registered on May 10, 2026.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: